These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8285884)

  • 1. Ganciclovir intraocular device and patient survival.
    Geier SA; Sadri I; Bogner JR; Goebel FD
    Arch Ophthalmol; 1994 Jan; 112(1):20; author reply 20-1. PubMed ID: 8285884
    [No Abstract]   [Full Text] [Related]  

  • 2. Ganciclovir intraocular device and patient survival.
    Spaide RF
    Arch Ophthalmol; 1994 Jan; 112(1):19-20; author reply 20-1. PubMed ID: 8285883
    [No Abstract]   [Full Text] [Related]  

  • 3. Ganciclovir intraocular device and patient survival.
    Morlet N; Young SH; Coroneo MT
    Arch Ophthalmol; 1994 Nov; 112(11):1404. PubMed ID: 7980124
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraocular sustained drug release devices.
    Irvine AR
    Arch Ophthalmol; 1995 Jan; 113(1):25-6. PubMed ID: 7826291
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
    Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
    Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cytomegalovirus retinitis in AIDS with an intraocular sustained-release ganciclovir implant].
    Mochizuki M; Ikeda E; Yoshimura K; Hikita N; Nagata Y; Iwamoto A; Fujino Y; Eguchi S; Oka S; Kimura S
    Nippon Ganka Gakkai Zasshi; 1998 Aug; 102(8):515-21. PubMed ID: 9754023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
    Desatnik HR; Foster RE; Lowder CY
    Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV retinitis: a clinical management update.
    Blanchet KD
    AIDS Patient Care STDS; 1996 Apr; 10(2):86-93. PubMed ID: 11361712
    [No Abstract]   [Full Text] [Related]  

  • 12. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
    Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release intravitreal ganciclovir pellets in the treatment of cytomegalovirus retinitis in the acquired immunodeficiency syndrome.
    Luckie A; Ai E
    Aust N Z J Ophthalmol; 1995 May; 23(2):157-8. PubMed ID: 7546694
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.
    Musch DC; Martin DF; Gordon JF; Davis MD; Kuppermann BD
    N Engl J Med; 1997 Jul; 337(2):83-90. PubMed ID: 9211677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
    Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
    Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphonoformate for CMV retinitis in AIDS.
    Colucciello M
    Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
    Martin DF; Kuppermann BD; Wolitz RA; Palestine AG; Li H; Robinson CA
    N Engl J Med; 1999 Apr; 340(14):1063-70. PubMed ID: 10194235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local therapy for cytomegalovirus retinopathy.
    Engstrom RE; Holland GN
    Am J Ophthalmol; 1995 Sep; 120(3):376-85. PubMed ID: 7661210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.